PRPO · NASDAQ · Medical - Diagnostics & Research

Precipio

Pairs hematologic-cancer pathology testing with proprietary diagnostic products.

$28.85
After-hours close+0.13 (+0.45%)
At close$28.72(−1.95%)
DateEstimateReportedSurprise
Nov 2026−$2.00
Aug 2026−$2.00−$0.12+94.0%
Mar 2026−$0.81
Nov 2025−$0.05
Aug 2025$0.05

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Aug 2020
May 2020
Mar 2020
Nov 2019
Aug 2019
May 2019
Apr 2019
Nov 2018
Aug 2018
May 2018
Apr 2018
Nov 2017
Aug 2017
May 2017
Apr 2017
Nov 2016
Aug 2016
May 2016
Apr 2016
Nov 2015
Aug 2015
May 2015
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 16, 2026−$2.00$1.7M
Aug 14, 2026−$2.00−$0.12+94.0%$1.7M$7.0M+319.2%
Mar 30, 2026−$0.81$8.0M
Nov 14, 2025−$0.05$6.2M
Aug 13, 2025$0.05$5.7M

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
May 14, 2025
Mar 27, 2025
Nov 6, 2024
Aug 13, 2024
May 14, 2024
Mar 29, 2024
Nov 13, 2023
Aug 11, 2023
May 12, 2023
Mar 30, 2023
Nov 10, 2022
Aug 11, 2022
May 11, 2022
Mar 30, 2022
Nov 12, 2021
Aug 12, 2021
May 14, 2021
Mar 29, 2021
Nov 13, 2020
Aug 13, 2020
May 14, 2020
Mar 27, 2020
Nov 13, 2019
Aug 9, 2019
May 16, 2019
Apr 16, 2019
Nov 19, 2018
Aug 17, 2018
May 21, 2018
Apr 13, 2018
Nov 20, 2017
Aug 21, 2017
May 18, 2017
Apr 13, 2017
Nov 14, 2016
Aug 12, 2016
May 23, 2016
Apr 14, 2016
Nov 12, 2015
Aug 13, 2015
May 14, 2015